Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,870 | 127,566 | 133,517 | 176,765 | 253,029 |
| Marketable Securities | 70,707 | 28,763 | 75,510 | 253,298 | 297,967 |
| TOTAL | $148,676 | $160,808 | $213,515 | $444,437 | $558,101 |
| Non-Current Assets | |||||
| PPE Net | 26,906 | 77,308 | 70,689 | 66,917 | 65,464 |
| Investments And Advances | 0 | 0 | 0 | 10,051 | 195,881 |
| Intangibles | 199,822 | 199,822 | 199,822 | 199,822 | 199,822 |
| Other Non-Current Assets | 41,486 | 63,082 | 81,273 | 101,493 | 110,139 |
| TOTAL | $268,214 | $340,212 | $351,784 | $378,283 | $571,306 |
| Total Assets | $416,890 | $501,020 | $565,299 | $822,720 | $1,129,407 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,669 | 5,210 | 4,108 | 2,857 | 2,219 |
| Accrued Expenses | 21,919 | 27,689 | 47,184 | 40,909 | 31,475 |
| Other current liabilities | 40,200 | N/A | N/A | 55,345 | 56,382 |
| TOTAL | $78,726 | $45,433 | $64,487 | $111,504 | $99,235 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 177,280 | 205,083 | 213,306 | 211,901 | 301,670 |
| TOTAL | $177,280 | $205,083 | $213,306 | $211,901 | $301,670 |
| Total Liabilities | $256,006 | $250,516 | $277,793 | $323,405 | $400,905 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 266,867 | 225,025 | 220,448 | 191,361 | 189,543 |
| Common Shares | 27 | 22 | 20 | 19 | 18 |
| Retained earnings | -1,849,016 | -1,604,850 | -1,338,091 | -1,054,836 | -785,360 |
| Other shareholders' equity | 28 | 14 | -60 | -4,327 | -1,366 |
| TOTAL | $160,884 | $250,504 | $287,506 | $499,315 | $728,502 |
| Total Liabilities And Equity | $416,890 | $501,020 | $565,299 | $822,720 | $1,129,407 |